D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Immunology D-index 74 Citations 16,081 222 World Ranking 1323 National Ranking 679
Medicine D-index 75 Citations 17,086 265 World Ranking 14731 National Ranking 7582

Overview

What is she best known for?

The fields of study she is best known for:

  • Gene
  • Cancer
  • Internal medicine

Her main research concerns Immunology, Chronic lymphocytic leukemia, Internal medicine, Leukemia and Cancer research. Her Immunology study frequently links to other fields, such as Risk factor. Her Chronic lymphocytic leukemia research includes elements of Cyclophosphamide, Disease, Bone marrow and Gene expression profiling.

Her research in Internal medicine intersects with topics in Gastroenterology and Oncology. Her Leukemia study combines topics in areas such as Monoclonal B-cell lymphocytosis and Monoclonal. In her research on the topic of Cancer research, Osteoclast is strongly related with Multiple myeloma.

Her most cited work include:

  • Clinical course and prognosis of smoldering (asymptomatic) multiple myeloma. (533 citations)
  • Expression of BCMA, TACI, and BAFF-R in multiple myeloma: a mechanism for growth and survival. (401 citations)
  • Expression of BCMA, TACI, and BAFF-R in multiple myeloma: a mechanism for growth and survival. (401 citations)

What are the main themes of her work throughout her whole career to date?

Her scientific interests lie mostly in Immunology, Chronic lymphocytic leukemia, Internal medicine, Cancer research and Molecular biology. Chronic lymphocytic leukemia is a subfield of Leukemia that Diane F. Jelinek investigates. Her Internal medicine research is multidisciplinary, incorporating elements of Gastroenterology and Oncology.

Her work in Cancer research tackles topics such as Multiple myeloma which are related to areas like Endocrinology. The study incorporates disciplines such as Cell culture, Antibody, Cellular differentiation and Biochemistry in addition to Molecular biology. Her B-cell activating factor research integrates issues from Receptor and Receptor expression.

She most often published in these fields:

  • Immunology (39.93%)
  • Chronic lymphocytic leukemia (35.82%)
  • Internal medicine (33.58%)

What were the highlights of her more recent work (between 2013-2021)?

  • Chronic lymphocytic leukemia (35.82%)
  • Immunology (39.93%)
  • Internal medicine (33.58%)

In recent papers she was focusing on the following fields of study:

Diane F. Jelinek focuses on Chronic lymphocytic leukemia, Immunology, Internal medicine, Antibody and Oncology. Chronic lymphocytic leukemia is a subfield of Leukemia that Diane F. Jelinek tackles. Her Immunology study combines topics from a wide range of disciplines, such as Cancer and Gene.

In her work, Stage is strongly intertwined with Gastroenterology, which is a subfield of Internal medicine. Her research investigates the connection between Antibody and topics such as Molecular biology that intersect with problems in Amyloid and Proteogenomics. Her research in Immunoglobulin light chain focuses on subjects like Multiple myeloma, which are connected to Monoclonal, Pathology, Cell culture and Bone marrow.

Between 2013 and 2021, her most popular works were:

  • Ibrutinib–Rituximab or Chemoimmunotherapy for Chronic Lymphocytic Leukemia (179 citations)
  • BCL2 mutations are associated with increased risk of transformation and shortened survival in follicular lymphoma (69 citations)
  • Clinical effect of stereotyped B-cell receptor immunoglobulins in chronic lymphocytic leukaemia: A retrospective multicentre study (64 citations)

In her most recent research, the most cited papers focused on:

  • Gene
  • Cancer
  • Internal medicine

Her primary areas of study are Antibody, Molecular biology, Immunology, Internal medicine and Chronic lymphocytic leukemia. Her work on Hypergammaglobulinemia is typically connected to Kappa, Molecular mass and Lambda as part of general Antibody study, connecting several disciplines of science. Her studies examine the connections between Molecular biology and genetics, as well as such issues in Immunoglobulin light chain, with regards to Polyclonal antibodies, Proteogenomics and Mass spectrometry.

Her Immunology study frequently draws connections to other fields, such as Cancer. Her Internal medicine study deals with Oncology intersecting with Hematology and Cohort. Her Chronic lymphocytic leukemia research includes themes of Gastroenterology, Immunoglobulin G and Retrospective cohort study.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Clinical course and prognosis of smoldering (asymptomatic) multiple myeloma.

Robert A. Kyle;Ellen D. Remstein;Terry M. Therneau;Angela Dispenzieri.
The New England Journal of Medicine (2007)

921 Citations

Expression of BCMA, TACI, and BAFF-R in multiple myeloma: a mechanism for growth and survival.

Anne J. Novak;Anne J. Novak;Jaime R. Darce;Jaime R. Darce;Bonnie K. Arendt;Bonnie K. Arendt;Brandon Harder;Brandon Harder.
Blood (2004)

599 Citations

Cloning and regulation of cholesterol 7 alpha-hydroxylase, the rate-limiting enzyme in bile acid biosynthesis.

Diane F. Jelinek;Stefan Andersson;Clive A. Slaughter;David W. Russell.
Journal of Biological Chemistry (1990)

507 Citations

Immunoglobulin free light chain ratio is an independent risk factor for progression of smoldering (asymptomatic) multiple myeloma

Angela Dispenzieri;Robert A. Kyle;Jerry A. Katzmann;Terry M. Therneau.
Blood (2008)

460 Citations

Comprehensive Assessment of Genetic and Molecular Features Predicting Outcome in Patients With Chronic Lymphocytic Leukemia: Results From the US Intergroup Phase III Trial E2997

Michael R. Grever;David M. Lucas;Gordon W. Dewald;Donna S. Neuberg.
Journal of Clinical Oncology (2007)

446 Citations

Ibrutinib–Rituximab or Chemoimmunotherapy for Chronic Lymphocytic Leukemia

Tait D. Shanafelt;Xin V. Wang;Neil E. Kay;Curtis A. Hanson.
The New England Journal of Medicine (2019)

443 Citations

Combination chemoimmunotherapy with pentostatin, cyclophosphamide, and rituximab shows significant clinical activity with low accompanying toxicity in previously untreated B chronic lymphocytic leukemia

Neil E. Kay;Susan M. Geyer;Timothy G. Call;Tait D. Shanafelt.
Blood (2006)

417 Citations

Prospective Evaluation of Clonal Evolution During Long-Term Follow-Up of Patients With Untreated Early-Stage Chronic Lymphocytic Leukemia

Tait D. Shanafelt;Thomas E. Witzig;Stephanie R. Fink;Robert B. Jenkins.
Journal of Clinical Oncology (2006)

332 Citations

Regulated Expression of BAFF-Binding Receptors during Human B Cell Differentiation

Jaime R. Darce;Bonnie K. Arendt;Xiaosheng Wu;Diane F. Jelinek.
Journal of Immunology (2007)

323 Citations

Chronic Lymphocytic Leukemia

Neil E. Kay;Terry J. Hamblin;Diane F. Jelinek;Gordon W. Dewald.
Hematology (2002)

313 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Diane F. Jelinek

Neil E. Kay

Neil E. Kay

Mayo Clinic

Publications: 126

Tait D. Shanafelt

Tait D. Shanafelt

Stanford University

Publications: 102

John C. Byrd

John C. Byrd

University of Cincinnati

Publications: 94

Kenneth C. Anderson

Kenneth C. Anderson

Harvard University

Publications: 85

Michael Hallek

Michael Hallek

University of Cologne

Publications: 76

Paolo Ghia

Paolo Ghia

Vita-Salute San Raffaele University

Publications: 72

Stephan Stilgenbauer

Stephan Stilgenbauer

University of Ulm

Publications: 70

Shaji Kumar

Shaji Kumar

Mayo Clinic

Publications: 68

Ola Landgren

Ola Landgren

University of Miami

Publications: 67

S. Vincent Rajkumar

S. Vincent Rajkumar

Mayo Clinic

Publications: 66

Susan L. Slager

Susan L. Slager

Mayo Clinic

Publications: 64

Michael J. Keating

Michael J. Keating

The University of Texas MD Anderson Cancer Center

Publications: 64

Robert A. Kyle

Robert A. Kyle

Mayo Clinic

Publications: 64

Stephen M. Ansell

Stephen M. Ansell

Mayo Clinic

Publications: 63

William G. Wierda

William G. Wierda

The University of Texas MD Anderson Cancer Center

Publications: 61

Thomas E. Witzig

Thomas E. Witzig

Mayo Clinic

Publications: 60

Trending Scientists

Lester W. Johnson

Lester W. Johnson

Swinburne University of Technology

Michael W. Klein

Michael W. Klein

Tufts University

William H. Gates

William H. Gates

Microsoft (United States)

Massimiliano Di Penta

Massimiliano Di Penta

University of Sannio

Jinhua Chen

Jinhua Chen

Hunan University

Dan Du

Dan Du

Washington State University

De-Yi Wang

De-Yi Wang

Madrid Institute for Advanced Studies

Ravi K. Nalla

Ravi K. Nalla

Microsoft (United States)

Chuankuan Wang

Chuankuan Wang

Northeast Forestry University

Thomas Carell

Thomas Carell

Ludwig-Maximilians-Universität München

Jeremy F. Reiter

Jeremy F. Reiter

University of California, San Francisco

Alex M. Thomson

Alex M. Thomson

University College London

Radek Spisek

Radek Spisek

Sotio (Czechia)

Andrew E. Arai

Andrew E. Arai

National Institutes of Health

David T. Armstrong

David T. Armstrong

University of Adelaide

Allen W. Cowley

Allen W. Cowley

Medical College of Wisconsin

Something went wrong. Please try again later.